Jeremy T Larsen Selected Research

Lenalidomide (CC 5013)

11/2022	Iberdomide plus dexamethasone in heavily pretreated late-line relapsed or refractory multiple myeloma (CC-220-MM-001): a multicentre, multicohort, open-label, phase 1/2 trial.
4/2016	Consolidation and Maintenance Therapies for Newly Diagnosed Multiple Myeloma in the Era of Novel Agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeremy T Larsen Research Topics

Disease

10	Multiple Myeloma 01/2023 - 09/2011
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 11/2020
2	Amyloidosis 01/2022 - 01/2018
2	Immunoglobulin Light-chain Amyloidosis 01/2022 - 01/2021
2	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 08/2013
1	COVID-19 01/2023
1	Sepsis (Septicemia) 11/2022
1	Toxic Optic Neuropathy 10/2022
1	Mast-Cell Leukemia (Leukemia, Mast Cell) 01/2022
1	Systemic Mastocytosis 01/2022
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2021
1	Inflammation (Inflammations) 01/2019
1	Hypoalbuminemia 01/2019
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2017
1	Neoplasms (Cancer) 04/2016

Drug/Important Bio-Agent (IBA)

2	Lenalidomide (CC 5013)FDA Link 11/2022 - 04/2016
2	Proteasome InhibitorsIBA 11/2022 - 01/2022
2	Dexamethasone (Maxidex)FDA LinkGeneric 11/2022 - 01/2022
2	Bortezomib (Velcade)FDA Link 01/2022 - 01/2018
1	Immunoglobulin G (IgG)IBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	iberdomideIBA 11/2022
1	pomalidomideIBA 11/2022
1	Immunomodulating AgentsIBA 11/2022
1	Immunoconjugates (Immunoconjugate)IBA 10/2022
1	B-Cell Maturation AntigenIBA 10/2022
1	belantamab mafodotinIBA 10/2022
1	ixazomibIBA 01/2022
1	midostaurinIBA 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2021
1	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 01/2021
1	CytokinesIBA 01/2019
1	MK 2206IBA 08/2017
1	Rituximab (Mabthera)FDA Link 08/2017
1	Bendamustine Hydrochloride FDA Link 08/2017
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 08/2013
1	Cladribine FDA LinkGeneric 08/2013
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 08/2013
1	thymoglobulin FDA Link 08/2013

Therapy/Procedure

11	Therapeutics 01/2023 - 09/2011
1	Drug Tapering 10/2022
1	Precision Medicine 11/2020
1	Hematopoietic Stem Cell Transplantation 01/2019
1	Stem Cell Transplantation 01/2018